Last quote by Michael Yee
Michael Yee quotes
The hep C numbers are a little light in the USA and that could be due to higher rebating and more competition.
Our read of the FDA comments suggest commentary in line with a reasonably high likelihood of approval.
It was a strong overall quarter, driven by strong Japan sales, but U.S. sales were lighter than expected. Japan is likely taking a price reduction for Gilead's drugs, so there will be questions about that.
The most prolific growth story in the large-cap biotech for the last three years just guided sales down. To some extent they are a victim of their own success.